AstraZeneca
Retrospective study backs Iressa use in oesophageal cancer
November 5, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Cancer Oesophagus Gefitinib, Iressa, gefitinib, oncology
A group of oesophageal cancer patients can increase their survival by six months or more if treated with AstraZeneca’s Iressa, …
AstraZeneca buys biotech Definiens
November 4, 2014Research and Development, Sales and Marketing AstraZeneca, Janssen, MedImmune, Pharmacyclics, binnig, definiens
AstraZeneca has strengthened its oncology capabilities with the acquisition of Definiens, a German company that has pioneered cancer imaging and …
AstraZeneca completes respiratory deal with Almirall
November 3, 2014Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory
AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …
AZ oncology drug a ‘Phoenix from the flames’
October 27, 2014Sales and Marketing AstraZeneca, CHMP, EC, lynparza, olaparib, oncology
As the possibility of a deal with Pfizer fades, AstraZeneca is continuing its argument for independence as a key cancer …
AstraZeneca deepens Cambridge ties
October 16, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, CRUK, Cambridge, MRC, MedImmune
AstraZeneca along with its biologics R&D arm MedImmune are to enter into four new collaborations with the University of Cambridge. …
AstraZeneca president to lead Sanofi UK
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Sanofi, Tarja Stenvall
Sanofi has appointed Tarja Stenvall to be its new general manager for the UK and Ireland. Stenvall joins Sanofi from …
MedImmune and CRUK team up on cancer
September 25, 2014Sales and Marketing AstraZeneca, CRT, CRUK, Cambridge, Cancer, MedImmune
AstraZeneca’s biologics arm MedImmune has joined forces with Cancer Research UK to establish a new research laboratory in Cambridge, UK. …
ABPI and BIA establish new manufacturing partnership
September 23, 2014Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip
The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …
AstraZeneca teams up with rival Lilly for Alzheimer’s
September 16, 2014Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly
AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …
Bristol-Myers Squibb: following the string of pearls
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions
Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …
Mixed results for AZ’s troubled Brilinta
September 3, 2014Sales and Marketing AstraZeneca, Brilinta, EMA, PCI, atlantic, heart, stent
The latest trial for AstraZeneca’s heart drug Brilinta (ticagrelor) has failed to meet expected results but suggests more flexible applications …
AZ shares climb on positive cancer drug news
September 1, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Pfizer, immunoc-oncology, pd-1
AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …
AstraZeneca and Illumina in new partnership
August 26, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Illumina, NGS technology, next generation sequencing
AstraZeneca has announced that it will develop next generation sequencing (NGS) for companion diagnostic tests in a new partnership with …
AZ launches US digital tool ‘DoctorsNotes’ in US
August 26, 2014Medical Communications, Sales and Marketing AstraZeneca, CME, CPD, apps, digital
AstraZeneca has launched a new online tool in the US called DoctorsNotes to help medical professionals keep better up to …
AstraZeneca shores up defences against Pfizer
August 22, 2014Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger
AstraZeneca has been making a series of big deals over the past three months as it looks to close the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
